10 June 2025 Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serious Diseases read more
28 May 2025 Aktis Oncology Initiates Phase 1b Clinical Trial Of Its Nectin-4- Targeting Radiopharmaceutical Product Candidate, Aky-1189, Across Multiple Tumor Types read more
23 May 2025 Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi read more
2 April 2025 Vida Ventures Taps Industry Heavyweights from JP Morgan and MPM BioImpact to Further Power Leadership Team read more
24 February 2025 Halda Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating HLD-0915 in Metastatic Castration-Resistant Prostate Cancer read more
